Mark P. Colonnese

Biota Pharmaceuticals

Former Executive Vice President and Chief Financial Officer

Overview

Mark P. Colonnese made an average of $665.8K in compensation at Biota Pharmaceuticals from 2016 to 2018.

Annual data

2018

In 2018, Mark P. Colonnese earned a total compensation of $639.4K as Former Executive Vice President and Chief Financial Officer at Biota Pharmaceuticals.

Ranking8,711 out of 10,741
Percentile18.9%

Mark P. Colonnese's 2018 compensation ranked 8,711th out of 10,741 executive pay records tracked by us this year.

Colonnese earned more than 18.9% of all executives tracked by us in 2018.

Industry groupDrugs
Ranking1,016 out of 1,199
Percentile15.3%

In the industry group of Drugs, Colonnese's pay ranked 1,016th out of 1,199 executive pay records tracked by us in 2018.

Colonnese earned more than 15.3% of executives in this group.

Salary$43,725
Other$595,656
Total$639,381

Colonnese received $595.7K in other compensation, which accounts for 93.16% of total compensation.

Colonnese also received $43.7K in salary.

2017

In 2017, Mark P. Colonnese earned a total compensation of $608K as Former Executive Vice President and Chief Financial Officer at Biota Pharmaceuticals.

Ranking10,441 out of 13,682
Percentile23.7%

Mark P. Colonnese's 2017 compensation ranked 10,441st out of 13,682 executive pay records tracked by us this year.

Colonnese earned more than 23.7% of all executives tracked by us in 2018.

Industry groupDrugs
Ranking1,185 out of 1,547
Percentile23.4%

In the industry group of Drugs, Colonnese's pay ranked 1,185th out of 1,547 executive pay records tracked by us in 2017.

Colonnese earned more than 23.4% of executives in this group.

Option Awards$226,754
Salary$349,800
Other$31,442
Total$607,996

Colonnese received $349.8K in salary, which accounts for 57.53% of total compensation.

Colonnese also received $226.8K in option awards and $31.4K in other compensation.

2016

In 2016, Mark P. Colonnese earned a total compensation of $749.9K as Executive Vice President and Chief Financial Officer at Biota Pharmaceuticals.

Ranking9,537 out of 14,016
Percentile32.0%

Mark P. Colonnese's 2016 compensation ranked 9,537th out of 14,016 executive pay records tracked by us this year.

Colonnese earned more than 32.0% of all executives tracked by us in 2018.

Industry groupDrugs
Ranking1,004 out of 1,495
Percentile32.8%

In the industry group of Drugs, Colonnese's pay ranked 1,004th out of 1,495 executive pay records tracked by us in 2016.

Colonnese earned more than 32.8% of executives in this group.

Non-Equity Incentive Plan$48,400
Option Awards$291,713
Salary$233,750
Other$176,082
Total$749,945

Colonnese received $291.7K in option awards, which accounts for 38.90% of total compensation.

Colonnese also received $48.4K in non-equity incentive plan, $233.8K in salary and $176.1K in other compensation.

Transgenomic

Executive Vice President and Chief Financial Officer

Annual data

2012

In 2012, Mark P. Colonnese earned a total compensation of $296.4K as Executive Vice President and Chief Financial Officer at Transgenomic.

Ranking9,859 out of 11,064
Percentile10.9%

Mark P. Colonnese's 2012 compensation ranked 9,859th out of 11,064 executive pay records tracked by us this year.

Colonnese earned more than 10.9% of all executives tracked by us in 2018.

Industry groupLaboratory Apparatus And Analytical, Optical, Measuring, and Controlling Instruments
Ranking164 out of 189
Percentile13.2%

In the industry group of Laboratory Apparatus And Analytical, Optical, Measuring, and Controlling Instruments, Colonnese's pay ranked 164th out of 189 executive pay records tracked by us in 2012.

Colonnese earned more than 13.2% of executives in this group.

Option Awards$198,250
Salary$96,106
Other$2,056
Total$296,412

Colonnese received $198.3K in option awards, which accounts for 66.88% of total compensation.

Colonnese also received $96.1K in salary and $2.1K in other compensation.